Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, Jeni’s mum, is now calling for the reclassification of the drug, claiming ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
US Weekly on MSN7d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
A now-former Iowa paramedic is facing charges after allegedly giving a man in need the wrong medication — and then failing to ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
They've found recreational use has grown dramatically over the past decade. It increased more than 80 percent from 2015 to ...
A Colne man who lost his football scholarship in America due to a ketamine addiction is warning people about the dangers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback